Clinical Trials Browser

INDUSTRY × Vincristine × Plasma cell × Clear all

NCT00441168 2014-03-21

Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma

Phase 2 Terminated

30 enrolled 14 charts

Multiple Myeloma, Neoplasms, Recurrence

NCT00344422 2011-06-10

Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell